Page last updated: 2024-10-31

mitoxantrone and Myotonic Dystrophy

mitoxantrone has been researched along with Myotonic Dystrophy in 1 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Myotonic Dystrophy: Neuromuscular disorder characterized by PROGRESSIVE MUSCULAR ATROPHY; MYOTONIA, and various multisystem atrophies. Mild INTELLECTUAL DISABILITY may also occur. Abnormal TRINUCLEOTIDE REPEAT EXPANSION in the 3' UNTRANSLATED REGIONS of DMPK PROTEIN gene is associated with Myotonic Dystrophy 1. DNA REPEAT EXPANSION of zinc finger protein-9 gene intron is associated with Myotonic Dystrophy 2.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hashem, VI1
Pytlos, MJ1
Klysik, EA1
Tsuji, K1
Khajavi, M1
Khajav, M1
Ashizawa, T1
Sinden, RR1

Other Studies

1 other study available for mitoxantrone and Myotonic Dystrophy

ArticleYear
Chemotherapeutic deletion of CTG repeats in lymphoblast cells from DM1 patients.
    Nucleic acids research, 2004, Volume: 32, Issue:21

    Topics: Alleles; Antineoplastic Agents, Alkylating; Cell Line; Doxorubicin; Ethyl Methanesulfonate; Humans;

2004